Michael A Black Selected Research

Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary)

3/2022	E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.
1/2019	E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Black Research Topics

Disease

20	Neoplasms (Cancer) 03/2022 - 08/2008
17	Breast Neoplasms (Breast Cancer) 12/2021 - 05/2008
8	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2008
4	Stomach Neoplasms (Stomach Cancer) 03/2022 - 01/2019
3	Melanoma (Melanoma, Malignant) 05/2015 - 08/2008
3	Pre-Eclampsia (Preeclampsia) 09/2014 - 01/2009
2	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 03/2022 - 01/2019
2	Gout 12/2014 - 03/2014
1	Triple Negative Breast Neoplasms 09/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Glioma (Gliomas) 11/2018
1	Rectal Neoplasms (Rectal Cancer) 03/2015
1	Disease Progression 07/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Carcinogenesis 01/2012
1	Myocardial Infarction 01/2012
1	Heart Diseases (Heart Disease) 01/2012
1	Lymphatic Metastasis 11/2011
1	Acute Coronary Syndrome 05/2011
1	Acute-Phase Reaction 06/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2009

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2007
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2009
6	Biological ProductsIBA 01/2021 - 08/2008
5	Phenobarbital (Luminal)FDA Link 01/2018 - 05/2012
4	Cadherins (E-Cadherin)IBA 03/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
3	RNA (Ribonucleic Acid)IBA 09/2021 - 05/2015
3	Small Interfering RNA (siRNA)IBA 04/2017 - 01/2012
3	Messenger RNA (mRNA)IBA 04/2017 - 01/2012
3	Estrogen ReceptorsIBA 04/2017 - 02/2010
2	Protein Isoforms (Isoforms)IBA 03/2022 - 01/2009
2	Interleukin-2 (IL2)IBA 10/2018 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2018 - 02/2007
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2017 - 07/2012
2	Tamoxifen FDA LinkGeneric 07/2012 - 11/2011
2	LigandsIBA 02/2010 - 05/2008
2	Complement System Proteins (Complement)IBA 06/2009 - 01/2009
1	Dasatinib (BMS 354825)FDA Link 03/2022
1	Serine-Threonine Kinase 3IBA 03/2022
1	entinostat (MS 275)IBA 12/2021
1	Long Noncoding RNAIBA 09/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	CytokinesIBA 01/2021
1	Circulating Tumor DNAIBA 11/2020
1	Carcinoembryonic AntigenIBA 11/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Serine (L-Serine)FDA Link 09/2019
1	Tryptophan (L-Tryptophan)FDA Link 11/2018
1	EnzymesIBA 08/2018
1	Doxycycline (Periostat)FDA LinkGeneric 08/2018
1	TransferasesIBA 08/2018
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2018
1	Co-Repressor ProteinsIBA 01/2018
1	Estrogens (Estrogen)FDA Link 04/2017
1	CytosineIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	NetrinsIBA 05/2015
1	Uric Acid (Urate)IBA 12/2014
1	High Fructose Corn SyrupIBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	Sucrose (Saccharose)IBA 12/2014
1	SugarsIBA 12/2014
1	MonosaccharidesIBA 12/2014
1	FructoseIBA 12/2014
1	angiogeninIBA 09/2014
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014
1	Cytochrome P-450 CYP2C9IBA 03/2014
1	BenzbromaroneIBA 03/2014
1	Allopurinol (Remid)FDA LinkGeneric 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	CyclinsIBA 07/2012
1	Cyclin EIBA 07/2012
1	ClaudinsIBA 05/2012
1	E2F Transcription FactorsIBA 01/2012
1	IronIBA 11/2011
1	Neutralizing AntibodiesIBA 08/2011
1	Kazal Pancreatic Trypsin InhibitorIBA 08/2011
1	AntibodiesIBA 05/2011
1	Streptokinase FDA Link 05/2011
1	Diethylstilbestrol (Stilbestrol)FDA Link 02/2010
1	Estrogen Receptor alphaIBA 02/2010
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2010
1	ProteomeIBA 06/2009
1	HDL LipoproteinsIBA 06/2009
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2009

Therapy/Procedure

6	Therapeutics 04/2017 - 01/2012
5	Drug Therapy (Chemotherapy) 03/2022 - 01/2013
3	Chemoprevention 03/2022 - 09/2019
3	Neoadjuvant Therapy 01/2021 - 01/2014
1	Radiation Dosimeters 01/2021
1	Immunotherapy 10/2018
1	Carotid Endarterectomy 01/2012